- Presentations
- 2
- Markets
- 1
Ogivri is a brand of Trastuzumab marketed by Mylan Institutional, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Trastuzumab
- Brand owner
- Mylan Institutional
- Registered in
- United States
- Strengths and forms
- kit, 150 mg/7.4 mL powder for injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Ogivri kit Cold chain | Mylan Institutional | US FDA | Available on request |
| Ogivri 150 mg/7.4 mL powder for injectionIntravenous Cold chain | Mylan Institutional | US FDA | Available on request |
Equivalent brands
Other brands of Trastuzumab.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Ogivri
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.